Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.
about
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model.Management of osteoporosis of the oldest old.Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.
P2860
Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Alendronate sodium hydrate (or ...... , easy to swallow formulation.
@en
type
label
Alendronate sodium hydrate (or ...... , easy to swallow formulation.
@en
prefLabel
Alendronate sodium hydrate (or ...... , easy to swallow formulation.
@en
P2860
P921
P356
P1476
Alendronate sodium hydrate (or ...... , easy to swallow formulation.
@en
P2093
Kazuhiro Imai
P2860
P304
P356
10.2147/CIA.S37199
P407
P577
2013-06-07T00:00:00Z